EUVIMEDEUVIMED entdecken
Crossref

Schizophrenic Phenotype and Therapeutic Course Associated With Chromosome 22q11.2 Deletion in a Cohort Without Prior Diagnosis of Chromosome 22q11.2 Deletion Syndrome

Micha Gawlik, Paul Schneider, Bruno Pfuhlmann, Jürgen Deckert

American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · 2026

DOI: 10.1002/ajmgb.70008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2026. Verfasst von Micha Gawlik und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Helios Fachkliniken Hildburghausen, Hildburghausen, Germany. Hauptthemen laut MEDLINE: Schizophrenia, DiGeorge Syndrome, Chromosomes, Human, Pair 22, Chromosome Deletion. Die Arbeit nennt 40 Literaturangaben. Gefördert von: University Hospital of Würzburg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chromosome 22q11.2 deletion is the greatest single genetic factor predisposing to schizophrenia. The prevalence of schizophrenia reported ranges from 2% to 30% in patients with chromosome 22q11.2 deletion syndrome with a still discussed phenotype. In the present study 1177 patients diagnosed with schizophrenia, schizoaffective disorder or affective disorder according to ICD‐10 criteria, none of which had been diagnosed with chromosome 22q11.2 deletion syndrome before, were screened for the chromosome 22q11.2 deletion or duplication applying TaqMan real‐time PCR. In six patients a deletion was found. The prevalence of the chromosome 22q11.2 deletion in the study population was 0.5%. According to ICD‐10, three patients were diagnosed with paranoid schizophrenia and three with schizoaffective disorder. Applying the differentiated criteria of Karl Leonhard, four patients were diagnosed with affect‐laden paraphrenia. Patients were treated with antipsychotics with varying success and the course of the disease ranged from full remission to severe residuum. Given the relevant prevalence of chromosome 22q11.2 deletion in an unselected population like the present one, a general screening of schizophrenic patients is discussed given the potentially severe, but treatable symptoms of the syndrome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SchizophreniaDiGeorge SyndromeChromosomes, Human, Pair 22Chromosome DeletionHumansPhenotypeFemaleMaleAdultCohort StudiesAntipsychotic Agents

Stichwörter der Autor:innen

affective paraphreniaantipsychotic therapychromosome 22q11.2 deletionreal‐time PCRschizophreniascreening

Substanzen

Antipsychotic Agents

Autor:innen und Institutionen

  • Department of Psychiatry, Helios Fachkliniken Hildburghausen, Hildburghausen, Germany.
  • Department of Psychotherapy, Helios Fachkliniken Hildburghausen, Hildburghausen, Germany.
  • Department of Psychiatry, Psychosomatics and Psychotherapy, Center of Mental Health, University Hospital Würzburg, Würzburg, Germany.
  • Department of Internal Medicine, Sozialstiftung Bamberg, Bamberg, Germany.
  • Department of Psychiatry and Psychotherapy, Städtisches Klinikum Dresden, Dresden, Germany.
  • Institute of Clinical Epidemiology and Biometrics, University of Würzburg, Würzburg, Germany.

Förderung

  • University Hospital of Würzburg

Zitieren

APA

Gawlik, M., Schneider, P., Pfuhlmann, B., & Deckert, J. (2026). Schizophrenic Phenotype and Therapeutic Course Associated With Chromosome 22q11.2 Deletion in a Cohort Without Prior Diagnosis of Chromosome 22q11.2 Deletion Syndrome. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. https://doi.org/10.1002/ajmgb.70008

Vancouver

Gawlik M, Schneider P, Pfuhlmann B, Deckert J. Schizophrenic Phenotype and Therapeutic Course Associated With Chromosome 22q11.2 Deletion in a Cohort Without Prior Diagnosis of Chromosome 22q11.2 Deletion Syndrome. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. 2026. doi:10.1002/ajmgb.70008

BibTeX
@article{Gawlik2026,
  author = {Gawlik, Micha and Schneider, Paul and Pfuhlmann, Bruno and Deckert, Jürgen},
  title = {Schizophrenic Phenotype and Therapeutic Course Associated With Chromosome 22q11.2 Deletion in a Cohort Without Prior Diagnosis of Chromosome 22q11.2 Deletion Syndrome},
  journal = {American Journal of Medical Genetics Part B: Neuropsychiatric Genetics},
  year = {2026},
  doi = {10.1002/ajmgb.70008}
}
Kostenlos starten →